KPP Advisory Services’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
KPP Advisory Services's HQL Position: Q1 2026 in Review
KPP Advisory Services increased its abrdn Life Sciences Investors (HQL) stake by 5.8% in Q1 2026, buying an estimated $22.6K and bringing the position to 24,591 shares worth $400K. The position accounts for 0.06% of the portfolio, ranked #243.
KPP Advisory Services first reported a position in HQL in Q3 2023 and has held it in 10 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.
- KPP Advisory Services held 24,591 shares of abrdn Life Sciences Investors worth $400K as of Q1 2026.
- KPP Advisory Services bought 1,354 abrdn Life Sciences Investors shares in Q1 2026, an estimated $22.6K.
- abrdn Life Sciences Investors made up 0.06% of KPP Advisory Services's portfolio in Q1 2026, its #243 holding.
- KPP Advisory Services first reported a position in abrdn Life Sciences Investors in Q3 2023 and has held it in 10 quarters since.
- 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.
Based on KPP Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.